IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Provectus Biopharmaceuticals

Q2 2016 vs Q3 2016

Comparing institutional holders between quarters

Quarters

Q3 2016Q2 2016Q1 2016Q4 2015Q3 2015
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile
Cormorant Asset Management, LP
UNCHANGED
Shares2,200,000 from 2,200,000
Change0 (0%)
Value$114 (-$300)
Filed 2016-11-14
Millennium Management LLC
UNCHANGED
Shares500,000 from 500,000
Change0 (0%)
Value$26 (-$79)
Filed 2016-11-14
Creative Planning
UNCHANGED
Shares149,570 from 149,570
Change0 (0%)
Value$8 (-$19)
Filed 2016-10-12
UBS Group AG
INCREASED
Shares9,926 from 5,536
Change+4,390 (+79%)
Value$1 ($0)
Filed 2016-11-14
Status
Cormorant Asset Management, LP
UNCHANGED2,200,0002,200,00000%$414$114-$3002016-11-14
Millennium Management LLC
UNCHANGED500,000500,00000%$105$26-$792016-11-14
Creative Planning
UNCHANGED149,570149,57000%$27$8-$192016-10-12
UBS Group AG
INCREASED9,9265,536+4,390+79%$1$1$02016-11-14
Showing 4 of 4 institutions